| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 56.50M | — |
| Operating expense | — | — |
| Net income | 8.20M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, PBYI returned +76.0% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +55.3% |
| 1 year | +76.0% |
| 5 years | +22.1% |
| 10 years | -84.4% |
| All-time high | $260.51 (Aug 2014) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in PBYI would be worth today ›No. Puma Biotechnology, Inc. has not paid a dividend in the past 12 months.
Puma Biotechnology, Inc. stock trades on NASDAQ under the ticker symbol PBYI.
Puma Biotechnology, Inc. is part of the Healthcare sector.
Puma Biotechnology, Inc. has a market cap of 476.97M USD, based on the latest quote.
Puma Biotechnology, Inc. is expected to report earnings around Nov 5, 2026. That date is an estimate and has not been confirmed by the company.
